Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration.

Mathur BN, Neely MD, Dyllick-Brenzinger M, Tandon A, Deutch AY
Brain Res. 2007 1168: 83-9

PMID: 17706185 · PMCID: PMC2040265 · DOI:10.1016/j.brainres.2007.06.076

MeSH Terms (13)

Animals Animals, Newborn Corpus Striatum Cysteine Proteinase Inhibitors Dopamine Male Motor Activity Nerve Degeneration Oligopeptides Organ Culture Techniques Rats Rats, Sprague-Dawley Substantia Nigra

Connections (2)

This publication is referenced by other Labnodes entities:

Links